Service
In our StemCell HUB we have multiple, well characterized control iPSC lines from healthy donors that can be requested for autonomous iPSC-related work.
Furthermore we are offering isogenic iPSC-line pairs (healthy/disease) for disease modelling of hypertrophic cardiomyopahty (HCM; MYBPC3 p.R943X) as well as dilated cardiomyopathy (DCM; RBM20 p.P635L; LMNA p.K117fs).
Beside these recources we are providing services regarding various aspects of iPSC-related research:
We are continously expanding our portfolio of iPSC-lines with specific functions like optogenetic based stimulation, fluorescence reporters, as well as CRISPRi/a systems.
Reprogramming
Reprogramming refers to the conversion of somatic cells, such as skin fibroblasts or blood cells, into induced pluripotent stem cells (iPSCs). This process is achieved by introducing defined transcription factors that reset the cells into a pluripotent state. The generated iPSCs can then be expanded indefinitely and differentiated into various cell types, providing a renewable source of patient-specific material for research and applications.
Genome Editing
Genome editing allows targeted changes to the DNA of stem cells. With tools such as CRISPR/Cas, specific genes can be knocked out, inserted, or corrected, enabling the creation of customized cellular models. Edited iPSCs can be used to study disease mechanisms, validate genetic findings, or establish isogenic control lines, thereby providing powerful tools for basic and translational research.
Quality Control
Quality control ensures that stem cell lines are reliable and safe to use in downstream experiments. It involves testing for pluripotency markers, verifying genomic stability, checking for mycoplasma or other contaminations, and confirming correct identity of the lines. These measures help to maintain reproducibility across projects and ensure that iPSCs remain suitable for differentiation and functional studies.